IDEAYA Biosciences (IDYA) Operating Margin (2020 - 2025)
IDEAYA Biosciences (IDYA) has disclosed Operating Margin for 6 consecutive years, with 869.53% as the latest value for Q4 2025.
- Quarterly Operating Margin rose 118959.0% to 869.53% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 72.84% through Dec 2025, up 459823.0% year-over-year, with the annual reading at 72.84% for FY2025, 459823.0% up from the prior year.
- Operating Margin hit 869.53% in Q4 2025 for IDEAYA Biosciences, down from 52.18% in the prior quarter.
- In the past five years, Operating Margin ranged from a high of 52.18% in Q3 2025 to a low of 2059.11% in Q4 2024.
- Historically, Operating Margin has averaged 519.11% across 5 years, with a median of 384.53% in 2022.
- Biggest five-year swings in Operating Margin: tumbled -99035bps in 2024 and later skyrocketed 118959bps in 2025.
- Year by year, Operating Margin stood at 620.16% in 2021, then fell by -6bps to 657.46% in 2022, then plummeted by -63bps to 1068.77% in 2023, then tumbled by -93bps to 2059.11% in 2024, then surged by 58bps to 869.53% in 2025.
- Business Quant data shows Operating Margin for IDYA at 869.53% in Q4 2025, 52.18% in Q3 2025, and 2059.11% in Q4 2024.